SDHC and head and neck squamous cell carcinoma: Given that all of these experiments were done using HPV- HNSCC, α-TOS may be even more toxic to HPV+ HNSCCs based on the correlation between SDHC expression and HPV+ HNSCC survival outcomes we observed.